Preparation of live attenuated mumps virus for a vaccine
First Claim
Patent Images
1. A method of preparing a live attenuated mumps virus for a vaccine comprising:
- incubating a wild mumps virus strain in a living cell selected from the group consisting of embryonated hen'"'"'s egg chorio-allantoic membrane, chick embryo fibroblast and human diploid cell for 1-18 passages sufficient to attenuate the virus, andsubjecting the thus attenuated virus to successive cultivation in a living cell selected from the group consisting of embryonated hen'"'"'s egg amnion, embryonated hen'"'"'s egg chorio-allantoic membrane and human diploid cell to propagate the virus.
0 Assignments
0 Petitions
Accused Products
Abstract
A live attenuated mumps virus vaccine is prepared by cultivating a wild mumps virus strain for 1-18 serial passages in a first living cell to attenuate the virus, and then cultivating the attenuated virus in a second living cell for at least one serial passage to propagate and adapt the virus to the cell. The cell is selected from embryonated hen'"'"'s egg amnion, embryonated hen'"'"'s egg chorio-allantoic membrane, chick embryo fibroblast and human diploid cell. Quail embryo fibroblast is also employed. The vaccine prepared has strong immunogenecity and is safe.
-
Citations
8 Claims
-
1. A method of preparing a live attenuated mumps virus for a vaccine comprising:
-
incubating a wild mumps virus strain in a living cell selected from the group consisting of embryonated hen'"'"'s egg chorio-allantoic membrane, chick embryo fibroblast and human diploid cell for 1-18 passages sufficient to attenuate the virus, and subjecting the thus attenuated virus to successive cultivation in a living cell selected from the group consisting of embryonated hen'"'"'s egg amnion, embryonated hen'"'"'s egg chorio-allantoic membrane and human diploid cell to propagate the virus. - View Dependent Claims (2, 3, 4, 5, 6)
-
-
7. A method of preparing a live attenuated mumps virus for a vaccine comprising:
-
incubating a wild mumps virus strain in a living cell selected from the group consisting of embryonated hen'"'"'s egg chorio-allantoic membrane, chick embryo fibroblast and human diploid cell for 1-18 passages sufficient to attenuate the virus; and subjecting the thus attenuated virus to successive cultivation in a living human diploid cell to propagate the virus.
-
-
8. A method of preparing a live attenuated mumps virus for a vaccine comprising:
-
incubating a wild mumps virus strain in a living human diploid cell for 1-18 serial passages sufficient to attenuate the virus; and subjecting the thus attenuated virus to successive cultivation in a living cell selected from the group consisting of embryonated hen'"'"'s egg amnion, embryonated hen'"'"'s egg chorio-allantoic membrane and human diploid cell to propagate the virus.
-
Specification